SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is actively trending following positive regulatory feedback that significantly de-risks its lead drug, sonelokimab, by allowing a Biologics License Application filing without additional trials. This pivotal development, coupled with recent analyst upgrades and upcoming investor events, has fueled extensive community speculation about a potential strategic acquisition, with many anticipating substantial upside from the biotech's de-risked asset.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is a major talking point following news of Amazon Pharmacy offering Novo Nordisk's oral GLP-1 weight-loss pill, intensifying competitive concerns for HIMS which does not offer the product. This development, alongside a recent analyst downgrade, is fueling a deeply divided community, with many anticipating further declines while bullish investors view the significant pullback as an overblown reaction and a strategic long-term buying opportunity in the evolving telehealth market.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending as widespread frustration mounts over warmer-than-expected winter weather forecasts, severely impacting natural gas demand. The community is vocal about significant losses, widely labeling the leveraged ETF a "widow maker" due to its inherent decay, while others debate a potential reversal, citing oversold conditions and the possibility of a polar vortex.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

NovaBay Pharmaceuticals is experiencing extreme volatility, fueled by a substantial special cash dividend and intense speculation around a potential pivot to blockchain assets. Community discussion is sharply divided between those anticipating a major short squeeze and turnaround driven by investor David Lazar's involvement, and others warning of a potential pump and dump given underlying fundamental concerns.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings Limited is trending due to recent news of a private placement and a significant acquisition, alongside the expiration of its IPO lock-up period. This low-float Hong Kong stock has ignited a fierce debate within the community, with many anticipating a short squeeze reminiscent of other volatile "China plays," while others warn of a rapid pump-and-dump scenario.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is a focal point of investor discussion as the biotech community anticipates potential updates at the upcoming JP Morgan Healthcare Conference, with many expressing frustration over the stock's underperformance despite robust Briumvi sales and an active M&A environment. Conversations are heavily focused on Briumvi's strong market share growth and best-in-class profile, the significant potential of a future subcutaneous formulation, and persistent buyout speculation, especially as competing BTK inhibitors face recent setbacks.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing increased scrutiny following a price target trim by Goldman Sachs and ongoing market skepticism surrounding its potential acquisition of Warner Bros. Discovery. Community sentiment is sharply divided, with many expressing frustration over recent price declines and concerns about the WBD deal, while others view the current valuation as a compelling buying opportunity ahead of anticipated strong earnings results. Investors are closely watching for signs of strength and clarity, particularly with Q4 earnings approaching, which could prove pivotal for the stock's direction amidst persistent acquisition drama.

VisionWave Holdings, Inc. engages in the forefront of revolutionizing defense capabilities by integrating advanced artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. The company was founded on March 20, 2024 and is headquartered in Wilmington, DE.

VisionWave Holdings Inc.

VisionWave Holdings, Inc.

VisionWave Holdings (VWAV) is generating significant buzz following a series of strategic developments in its AI, defense, and drone technology sectors, including recent patent grants and acquisitions. The community is highly bullish, anticipating a major "parabolic" move or short squeeze driven by the stock's extremely low float and high institutional ownership, with many drawing comparisons to past high-growth stocks. Investors are also noting its "Strong Buy" rating from Nasdaq Dorsey Wright and successful pilot programs, signaling strong potential for commercialization and growth.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is experiencing heightened investor interest due to recent U.S. actions regarding Venezuela's immense oil reserves, where President Trump has indicated American oil companies, particularly those with existing operations like Chevron, will be heavily involved in rebuilding the sector. The community is actively discussing whether Chevron's unique positioning offers a significant long-term growth opportunity or if the substantial infrastructure investments and political risks present formidable challenges.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending as the market closely watches unfolding developments in Venezuela, with the US administration signaling that American oil companies could be heavily involved in revitalizing the nation's vast oil reserves. This potential for asset recovery and new investment is fueling bullish sentiment and discussions of significant upside. However, community conversations also highlight widespread concerns regarding market oversupply, political complexities, and the long-term feasibility of such ventures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alliance Resource Partners (NASDAQ:ARLP) Stock Rating Lowered by Zacks Research

Zacks Research lowered Alliance Resource Partners from a "hold" rating to a "strong sell" rating in a research report on Monday...

Alliance Resource Partners (NASDAQ:ARLP) Cut to Buy at Wall Street Zen

Wall Street Zen downgraded Alliance Resource Partners from a "strong-buy" rating to a "buy" rating in a research note on Saturday...

Sidoti Csr Has Negative Outlook of ARLP FY2026 Earnings

Alliance Resource Partners, L.P. (NASDAQ:ARLP - Free Report) - Research analysts at Sidoti Csr lowered their FY2026 earnings estimates for shares of Alliance Resource Partners in a report released on...

Sidoti Csr Equities Analysts Cut Earnings Estimates for ARLP

Alliance Resource Partners, L.P. (NASDAQ:ARLP - Free Report) - Investment analysts at Sidoti Csr cut their FY2025 EPS estimates for Alliance Resource Partners in a research report issued on Monday...

Should Value Investors Buy Alliance Resource Partners (ARLP) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Adams Asset Advisors LLC Sells 79,448 Shares of Alliance Resource Partners, L.P. $ARLP

Adams Asset Advisors LLC cut its position in shares of Alliance Resource Partners, L.P. (NASDAQ:ARLP - Free Report) by 23.7% in the third quarter, according to the company in its most recent...

Nomura Holdings Inc. Takes Position in Alliance Resource Partners, L.P. $ARLP

Nomura Holdings Inc. acquired a new position in Alliance Resource Partners, L.P. (NASDAQ:ARLP - Free Report) during the second quarter, according to its most recent disclosure with the Securities...

Crescent Grove Advisors LLC Increases Stake in Alliance Resource Partners, L.P. $ARLP

Crescent Grove Advisors LLC grew its holdings in Alliance Resource Partners, L.P. (NASDAQ:ARLP - Free Report) by 30.4% during the 2nd quarter, according to its most recent Form 13F filing with the...

Alliance Resource Partners (NASDAQ:ARLP) Rating Lowered to "Buy" at Wall Street Zen

Wall Street Zen lowered Alliance Resource Partners from a "strong-buy" rating to a "buy" rating in a research note on Sunday...

Alliance Resource Partners (NASDAQ:ARLP) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised Alliance Resource Partners from a "buy" rating to a "strong-buy" rating in a research note on Saturday...

Alliance Resource Partners LP is a natural resource company, which produces and markets coal to United States utilities and industrial users. It operates through the following segments: Illinois Basin, Appalachia, Minerals, and Other & Corporate. The Illinois Basin segment is comprised of Webster County coal's Dotiki mining complex, Gibson mining complex, which includes the Gibson north mine and the Gibson south project, Hopkins County coal's Elk Creek mining complex, White County coal's Pattiki mining complex, Warrior's mining complex, River View's mining complex, the Sebree property and certain properties of Alliance Resource Properties and ARP Sebree LLC. The Appalachian segment is composed of Pontiki and MC Mining complexes. The Minerals segment includes its oil & gas mineral interests, which are located primarily in the Permian, Anadarko, and Williston basins. The Other and Corporate segment includes marketing and administrative expenses, Mt. Vernon dock activities, coal brokerage activity, its equity investment in Mid-America Carbonates LLC and certain activities of Alliance Resource Properties. The company was founded in 1971 and is headquartered in Tulsa, OK.

Alliance Resource Partners, LP - Unit

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$24.36
Prev Close	$24.07
Open	$24.10
Dividend Yield	10.65%
50-Day Moving Average	$24.00
Beta	0.39
Avg. Volume	324,935.41
PE Ratio	12.73

52-Week High	$30.56
52-Week Low	$22.20
Market Capitalization	$3.09B
EPS (Annual)	$2.77
Price to Book	1.71
Revenue Per Employee	$670,327.95
Enterprise Value/EBITDA	N/A

ARLP
Alliance Resource Partners LP

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARLP News

ARLPAlliance Resource Partners LP